Success Story: Our Firm Guided a Scientist to Secure An NIW Success Without Any RFE Issues
Client’s Testimonial:
“Thank you for the update! It has been a long and anxious period of time while waiting for the approval. I am sincerely grateful for your service in making this case stronger.”
On February 18th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Scientist in the Field of Microbiology and Cell Science (Approval Notice).
General Field: Microbiology and Cell Science
Position at the Time of Case Filing: Scientist
Country of Origin: Taiwan
State of Residence at the Time of Filing: California
Approval Notice Date: February 18th, 2025
Processing Time: 9 months, 20 days (Premium Processing Upgrade Requested)
Case Summary:
The client, a distinguished researcher with a Ph.D. in microbiology and cell science, has earned approval for an I-140 petition under the EB2-NIW (National Interest Waiver) category. The case was built around the client’s expertise in developing optimized in vitro diagnostic tools to provide preventative healthcare solutions and treatment strategies for cancer and infectious diseases, an endeavor that holds both substantial merit and clear national importance to the United States.
The client’s extensive academic and research background in microbiology and cellular mechanisms established a strong foundation for the petition. Currently employed as a scientist in the biotechnology sector, the client continues to lead studies utilizing advanced molecular and cellular techniques to improve the accuracy, sensitivity, and specificity of diagnostic assays. These efforts directly contribute to improving early disease detection and reducing the burden of cancer and infectious disease management in the U.S. healthcare system.
To date, the client has authored 12 peer-reviewed journal articles, including 2 first-authored papers, which have collectively received over 300 citations according to Google Scholar – an impressive record that underscores the influence and utility of the client’s research among peers worldwide. The petition also highlighted the client’s ability to critically evaluate the work of others through participation as a peer reviewer, further confirming the client’s recognized expertise and leadership in the field.
In addition to these accomplishments, the petition demonstrated the client’s research funding from the National Institutes of Health (NIH), a major national agency that supports projects advancing public health. This endorsement from a leading federal research institution further validated the national significance and impact of the client’s contributions.
To strengthen the case, we included two letters of recommendation from experts in microbiology and molecular diagnostics, attesting to the originality, reliability, and importance of the client’s work in addressing critical challenges in diagnostic science.
“These accomplishments demonstrate [Client’s]competency to continue driving advancements, presenting significant benefits to both national and international scientific endeavors.”
Throughout the petition, we emphasized the client’s established record of scientific success, the documented use of the client’s research by peers, and the alignment of the proposed endeavor with U.S. healthcare priorities. By demonstrating the client’s exceptional qualifications and the direct national benefit of waiving the labor certification requirement, we secured approval of the I-140 NIW petition.
This case stands as another example of a successful outcome for an exceptional researcher whose innovative work in microbiology and diagnostic technology is making a measurable impact on healthcare and medical science.